A surge in the number of cannabis producers coupled with a large number of site-amendment requests in preparation for Cannabis 2.0 have left Health Canada “overwhelmed” over the past year, and increasingly dependent upon information supplied “in good faith” by producers, according to former Health Canada inspectors and industry participants.

The department has been overwhelmed for quite some time, but it is not necessarily their fault

Ontario’s former Assembly of First Nations regional chief said the government should legalize cannabis sales in Indigenous communities — and he’s willing to help it create the framework.

Isadore Day, now the CEO of a consulting group named Bimaadzwin, said Ottawa never discussed legalization with First Nations communities.

Day said the move prompted the group to set up its own shops on reserves. “We’re not the black market,” he told CBC. “We just haven’t been legitimized by Canada’s cannabis framework as of yet.”

New rules effective Dec. 16 will come just in time so you can leave a cannabis-laced cookie or beverage out for Santa.

But if the struggling Canadian pot business is looking forward to Cannabis 2.0  — as the availability of vaping products and edibles has been dubbed — they will likely be disappointed if they expect it to be a Christmas present that will solve their financial problems.

The sector that was so recently a stock market darling and that attracted small-scale entrepreneurs like moths to candle flames has suddenly fallen on hard times as heavier cannabis users, who make up the bulk of sales, simply don't patronize the legal market.

Canada’s black market drug dealers are now the world’s fourth largest exporters of cannabis, according to Public Safety Canada.

Citing a Public Safety Canada report — Patterns In Cannabis Cryptomarkets In Canada In 2018 — a Blacklock’s Reporter article says 2.5 tons of cannabis is now sold and shipped annually from Canada.

Dealers using cryptomarkets or black market websites for illegal sales now rank fourth behind their counterparts in the U.S., U.K. and Germany, says the Public Safety Canada report.

“Prior to legalization Canada ranked eighth for cannabis revenues,” added the report.

After Parliament legalized pot in 2018, Public Safety Canada says “sophisticated criminal entrepreneurs” used the law to wildly increase black market Internet sales.

The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX:TGOD) (US:TGODF), a leading producer of premium certified organic cannabis, is pleased to announce that it has received orders from Alberta, Manitoba and Nova Scotia to be shipped this month, significantly expanding its Canadian distribu

There was a time just a few short months ago that buying into the world of legal cannabis seemed like a sure thing.

But that optimism has gone up in smoke.

A major pot stock sell off continued on markets Monday, partially because consumers are less than enthused about legally available cannabis. 

In theory, the black market should be under tremendous pressure now, by the new regulated and ultimately safe marijuana supply sanctioned by provincial governments in Canada.

Read entire article here.

During the last month, several leading Canadian cannabis companies have reported quarterly financial results and the market has been responding negatively to these numbers (on average). Although these companies have reported strong growth when compared to prior periods, the numbers have come in below expectations and the market has punished these companies for such results.

Today, people use cannabis products such as CBD for numerous medicinal benefits, here we find out how it can help in treating anxiety

Cannabis products such as CBD (cannabidiol) oil have become mainstream trends in health and wellness. Although the use of cannabis for medicinal benefits spans many centuries, products from the plant have been Schedule I for a long time. Many people are still adjusting to the therapeutic benefits of cannabis. In the US, after the passing of the 2018 Farm Bill, manufacturers began to produce various hemp-derived cannabis products. FDA-approved Epidiolex for seizures also became the first legal cannabis-based medication.

At this time last year, there arguably wasn't a hotter or more popular investment opportunity than marijuana stocks. It's not hard to understand why, either, if you simply look at the industry's recent growth trends or Wall Street's sales forecasts.

Shares of Canadian pot producer HEXO (HEXO.TO)(HEXO) fell to a two-year low after the company revealed late Friday that it grew cannabis in a space “not adequately licenced” by Health Canada at a Niagara, Ont. facility. Now, analysts are asking why it took months for the company to tell investors after management discovered the lapse.

The public admission by Gatineau, Que.-based HEXO came more than two-and-a-half months after the company said it discovered its “Block B” room inside a building formerly-owned by Newstrike Brands was not fully licenced on July 30. Hexo acquired Newstrike Brands on March 28 for $263 million.